← BACK TO SEARCH RESULTS
Brian Cunniff, PhD
Assistant Professor, Pathology and Laboratory Medicine-Research
Honorary Visiting Fellow, Department of Genetics, Genomics and Cancer Sciences University of Leicester, UK
Cancer Cell (CC)
Graduate Students in Lab
Key Areas of Interest / Study
Experimental therapeutics, Mechanisms of carcinogenesis, Medicinal chemistry/drug development, Oncogenic cell signaling, Other, REDOX biology
Academic Interests
The Cunniff Lab investigates features of malignant tumor cells that provide a vulnerability that can be exploited through development and use of redox active anti-cancer compounds. We conduct basic science research, compound screening and translational research to support clinical development of new therapies. Dr. Cunniff's research is supported by the NIH, philanthropic donations, and industry sponsorship.
Awards, Honors, and Appointments
Honorary Visiting Fellow, Department of Genetics, Genomics and Cancer Sciences University of Leicester, UK
Juckett Faculty Scholar, UVM Cancer Center
Council Member - Society for Redox Biology and Medicine (Nov 2024-)
Council Member - Society for Redox Biology and Medicine (Nov 2024-)
Juckett Faculty Scholar, UVM Cancer Center
Council Member - Society for Redox Biology and Medicine (Nov 2024-)
Council Member - Society for Redox Biology and Medicine (Nov 2024-)
News Stories
16-JAN-26 - Brian Cunniff, Ph.D., Named Inaugural Juckett Faculty Scholar at the UVM Cancer Center
4-MAY-26 - New research identifies covalent inhibitors as a potential cancer therapy
21-JUN-26 - A Promising Cancer Discovery Moves Closer to the Clinic
14-JUL-26 - New Cancer Drug Shows Promise in Mesothelioma Trial
4-MAY-26 - New research identifies covalent inhibitors as a potential cancer therapy
21-JUN-26 - A Promising Cancer Discovery Moves Closer to the Clinic
14-JUL-26 - New Cancer Drug Shows Promise in Mesothelioma Trial

